Erratum to Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes[Cardiovasc Diabetol(2015) 14:118] DOI 10.1186/s12933-015-0266-4;Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes

Cardiovascular Diabetology

Volumn 14, Issue 1, 2015, Pages

  Monnier, Vincent M ^a   Sun, Wanjie ^b   Gao, Xiaoyu ^b   Sell, David R ^a   Cleary, Patricia A ^b   Lachin, John M ^b   Genuth, Saul ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

A1c; AGEs; Cardiac indices; Coronary artery calcium; DCCT EDIC; Intima media thickening

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CHEMICAL COMPOUND; COLLAGEN; GLUCOSEPANE; METHYLGLYOXAL HYDROIMIDAZOLONE DERIVATIVE; PENTOSIDINE; PEPSIN A; UNCLASSIFIED DRUG; ARGININE; BIOLOGICAL MARKER; FUROSINE; LYSINE; METHYLGLYOXAL;

ADOLESCENT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; CROSS LINKING; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; SKIN; ADULT; ANALOGS AND DERIVATIVES; ASYMPTOMATIC DISEASE; BIOPSY; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPLICATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 1; GLYCOSYLATION; HEART DISEASES; METABOLISM; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ODDS RATIO; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; VASCULAR CALCIFICATION; YOUNG ADULT;

ADULT; ARGININE; ASYMPTOMATIC DISEASES; BIOMARKERS; BIOPSY; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHI-SQUARE DISTRIBUTION; COLLAGEN; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART DISEASES; HUMANS; LOGISTIC MODELS; LYSINE; MAGNETIC RESONANCE IMAGING; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PEPSIN A; PYRUVALDEHYDE; RISK FACTORS; SKIN; TIME FACTORS; VASCULAR CALCIFICATION; YOUNG ADULT;

EID: 84940762470     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-015-0295-z     Document Type: Erratum

References (33)

1. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY et al (2003) Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 348:2294-2303
2. Turkbey EB, Jye-Yu C, Backlund M, Genuth S, Jain A, Miao C et al (2011) Myocardial structure, function, and scar in patients with type 1 diabetes mellitus. Circulation 124:1737-1746
3. Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W et al (1999) Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes 48:870-880
4. Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J et al (2005) Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 54:3103-3111
5. Genuth S, Sun W, Cleary P, Gao X, Sell DR, Lachin J et al (2015) Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes. Diabetes 64:266-278
6. Monnier VM, Sell DR, Strauch C, Sun W, Lachin JM, Cleary PA et al (2013) The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes. J Diabetes Complicat 27:141-149
7. Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY et al (2006) The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 55:3556-3565
8. Tobin J (1958) Estimation of relationships for limited dependent variables. Econometrica 26:24-36
9. SAS Institute I (1995) SAS/STAT User's guide, version 8. SAS Institute Inc, Cary
10. Lachin J (2000) Biostatistical Methods: the assessment of relative risks. Wiley, New York
11. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 54:289-300
12. DCCT/EDIC (2000) Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 342:381-389
13. van Eupen MG, Schram MT, Colhoun HM, Scheijen JL, Stehouwer CD, Schalkwijk CG (2013) Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification. Cardiovasc Diabetol 12:149
14. Wang Z, Jiang Y, Liu N, Ren L, Zhu Y, An Y et al (2012) Advanced glycation end-product Nepsilon-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes. Atherosclerosis. 221:387-396
15. Nagaraj RH, Sell DR, Prabhakaram M, Ortwerth BJ, Monnier VM (1991) High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc Natl Acad Sci USA 88:10257-10261
16. Liberman M, Johnson RC, Handy DE, Loscalzo J, Leopold JA (2011) Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification. Biochem Biophys Res Commun 413:436-441
17. Sell DR, Biemel KM, Reihl O, Lederer MO, Strauch CM, Monnier VM (2005) Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J Biol Chem 280:12310-12315
18. Sveen KA, Dahl-Jorgensen K, Stensaeth KH, Angel K, Seljeflot I, Sell DR et al (2015) Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes. J Diabetes Complications 29:407-412
19. Hanssen NM, Beulens JW, van Dieren S, Scheijen JL, van der A DL, Spijkerman AM et al (2015) Plasma advanced glycation endproducts are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL). Diabetes 64:257-265
20. Hu S, He W, Liu Z, Xu H, Ma G (2013) The accumulation of the glycoxidation product N(epsilon)-carboxymethyllysine in cardiac tissues with age, diabetes mellitus and coronary heart disease. Tohoku J Exp Med 230:25-32
21. Kizer JR, Benkeser D, Arnold AM, Ix JH, Mukamal KJ, Djousse L et al (2014) Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults. Atherosclerosis 235:116-121
22. Fu MX, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW (1994) Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 43:676-683
23. Cooper GJ, Young AA, Gamble GD, Occleshaw CJ, Dissanayake AM, Cowan BR et al (2009) A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study. Diabetologia 52:715-722
24. Cooper GJ (2012) Selective divalent copper chelation for the treatment of diabetes mellitus. Curr Med Chem 19:2828-2860
25. Frye EB, Degenhardt TP, Thorpe SR, Baynes JW (1998) Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J Biol Chem 273:18714-18719
26. Chong SA, Lee W, Arora PD, Laschinger C, Young EW, Simmons CA et al (2007) Methylglyoxal inhibits the binding step of collagen phagocytosis. J Biol Chem 282:8510-8520
27. Sassi-Gaha S, Loughlin DT, Kappler F, Schwartz ML, Su B, Tobia AM et al (2010) Two dicarbonyl compounds, 3-deoxyglucosone and methylglyoxal, differentially modulate dermal fibroblasts. Matrix Biol J Int Soc Matrix Biol 29:127-134
28. Yuen A, Laschinger C, Talior I, Lee W, Chan M, Birek J et al (2010) Methylglyoxal-modified collagen promotes myofibroblast differentiation. Matrix Biol J Int Soc Matrix Biol 29:537-548
29. Paul RG, Bailey AJ (1999) The effect of advanced glycation end-product formation upon cell-matrix interactions. Int J Biochem Cell Biol 31:653-660
30. Dobler D, Ahmed N, Song L, Eboigbodin KE, Thornalley PJ (2006) Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes 55:1961-1969
31. Golej J, Hoeger H, Radner W, Unfried G, Lubec G (1998) Oral administration of methylglyoxal leads to kidney collagen accumulation in the mouse. Life Sci 63:801-807
32. Sveen KA, Nerdrum T, Hanssen KF, Brekke M, Torjesen PA, Strauch CM et al (2014) Impaired left ventricular function and myocardial blood flow reserve in patients with long-term type 1 diabetes and no significant coronary artery disease: associations with protein glycation. Diab Vasc Dis Res. 11:84-91
33. Sun JK, Keenan HA, Cavallerano JD, Asztalos BF, Schaefer EJ, Sell DR et al (2011) Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study. Diabetes Care 34:968-974